title: Dynamic regulation and dysregulation of the water channel aquaporin-2: a common cause of and promising therapeutic target for water balance disorders.
abstract: The human body is two-thirds water. The ability of ensuring the proper amount of water inside the body is essential for the survival of mammals. The key event for maintenance of body water balance is water reabsorption in the kidney collecting ducts, which is regulated by aquaporin-2 (AQP2). AQP2 is a channel that is exclusively selective for water molecules and never allows permeation of ions or other small molecules. Under normal conditions, AQP2 is restricted within the cytoplasm of the collecting duct cells. However, when the body is dehydrated and needs to retain water, AQP2 relocates to the apical membrane, allowing water reabsorption from the urinary tubule into the cell. Its impairments result in various water balance disorders including diabetes insipidus, which is a disease characterized by a massive loss of water through the kidney, leading to severe dehydration in the body. Dysregulation of AQP2 is also a common cause of water retention and hyponatremia that exacerbate the prognosis of congestive heart failure and hepatic cirrhosis. Many studies have uncovered the regulation mechanisms of AQP2 at the single-molecule level, the whole-body level, and the clinical level. In clinical practice, urinary AQP2 is a useful marker for body water balance (hydration status). Moreover, AQP2 is now attracting considerable attention as a potential therapeutic target for water balance disorders which commonly occur in many diseases.
authors.affiliation: Department of Nephrology, Nakano General Hospital, 4-59-16 Chuo, Nakano-ku, Tokyo, 164-8607, Japan, ynodmed2@tmd.ac.jp.
authors.forename: Yumi
authors.initials: Y
authors.lastname: Noda
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D050034:Antidiuretic Agents / Q000627:therapeutic use; D051399:Aquaporin 2 / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism; D015195:Drug Design; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology; D008969:Molecular Sequence Data; D058990:Molecular Targeted Therapy; D009154:Mutation; D010766:Phosphorylation; D021381:Protein Transport; D015398:Signal Transduction; D014882:Water-Electrolyte Balance; D014883:Water-Electrolyte Imbalance / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology
chemical_list: D050034:Antidiuretic Agents; D051399:Aquaporin 2; D002118:Calcium